Nathan & Aaron began searching for cultivars that would provide the pain relief & euphoria that their brother searched for in cannabis without leaving him debilitatingly high: elusive type 2 & 3 cultivars that were dominant in CBD (cannabidiol). Little did they know, that search for genetics better suited for treating their brother’s symptoms would be a major differentiator for their future company, carrying it through the tough times ahead.

Read More